Woman’s Foundation’s Online CME Program offers free, on-demand access to a library of courses eligible for a maximum of 1.00 AMA PRA Category 1 Credits™ for each course. Courses include recordings from our live conferences and symposiums, as well as studio-produced courses featuring local and national experts. Our service enables Woman’s Foundation Online CME Program to become a virtual visitor to the homes and offices of physicians and allied health professionals, helping make the pursuit of lifelong learning convenient for learners in Louisiana and surrounding states.
Receive Online CME's from a Local Provider
Topics & Learning Objectives
To complete an online educational event, please complete the following steps:
- Click the topic you are interested in.
- Click the blue “BEGIN” button to enroll in the online educational event.
- Once you are prompted to the High Marks page, complete the pre-test.
- Click on Video/Documents to watch the corresponding presentation, this will bring you to a separate page.
- Return to the enduring material page and complete the post-test.
- Complete the session evaluation.
- On the top blue banner banner, click on “Claim CME Credits”, from this page you will be able to download a PDF of your CME certificate.
2021 Virtual Community Opioid Series
Accredited for Physicians, Nurses, LPCs and Social Workers
- Opioid Tapering - Corey Hayes, Pharm.D., Ph.D., MPH
- Opioid Exposure During Pregnancy and the Postpartum Period - Shona Ray-Griffith, MD
- Physical Therapy and the Opioid Crisis - Beau Saunier, PT, DPT, FAAOMPT
- Opioid Treatment Options: Mindfulness & Auricular Acupuncture - Adrianne Trogden, Ph.D., LAC, CCS, ADS, CFMHE, LPC-S
- Opioids and Louisiana - Attorney General Jeff Landry
- Motivational Interviewing: A Treatment Approach to the Opioid Epidemic - Lucy R. Cannon, LCSW, LICSW, CCDP-D, MATS
- Non Opioid Treatment Options for Pain Management - Kelly Boussert, MD
- Overview of the Louisiana Prescription Monitoring Program (PMP) - Joe Fontenot, R.PH.
- The Opioid Epidemic & Its Impact in Orthopedic Surgery/Physical Therapy - Otis Drew, MD & Beau Saunier, PT, DPT, FAAOMPT
- SAMHSA/DEA Guidelines for Treating Patients with Opioid Use Disorder - Sarah Hamauei, MD
- Non-Opioid Drug Treatments for Adult Outpatient Pain Management - Breannie Charles, PharmD, BCPS, AAHIVP, CSP
- Introduction to MAT and Importance of Harm Reduction - Lee Michals, MD & Howard Osofsky, MD
- Identify evidence-based practices for tapering opioids in patients using chronically.
- Discuss cases of opioid tapering.
- Describe currently available tools tailored to help the busy clinician with opioid tapering.
- Define the prevalence of opioid exposure during pregnancy
- Review the data for adverse perinatal outcomes associated with opioid exposure in utero
- Describe common patient presentations of opioid use disorder during pregnancy
- Discuss medication management of opioid use disorder
- Upon completion of the activity, participants will be able to describe the causes of pain
- Upon completion of the activity, participants will know what makes people susceptible to chronic pain
- Upon completion of the activity, participants will understand the role that physical therapists play in helping people overcome acute and chronic pain issues
- Identify mindfulness techniques to use with their patients/clients
- Comprehend the methodology and usage of auricular acupuncture
- Identify when to use or refer a patient/client for auricular acupuncture
- Understand how mindfulness techniques are effective in assisting patients to manage withdrawal symptoms, emotional dysregulation, and impulsivity
- Comprehended the complex network of cases against multiple pharmaceutical companies.
- Communicate knowledge of the extent of the programs being offered by LADOJ and how they can be accessed.
- Discuss the activities currently being undertaken by the LADOJ on the lawsuits, education and outreach, prevention and other programs provided by the LADOJ regarding opioid addiction.
- Discuss the current landscape of opioid lawsuits in Louisiana and provisions being made for the funds post settlements. It should be addressed because law makers are deciding were this funding will be spent.
- To define the purpose and spirit of Motivational Interviewing when treating individuals with Opioids and other substance use disorders.
- To identify the signs and symptoms of different stages of opioid use and commonly abused prescription medications.
- Participants will identify key factors in developing an MI therapeutic alliance that will enable healthcare professionals to help clients express their feelings problems, and impact on behavior.
- Participants will explain and cite examples of various MI techniques ( e.g. OARS and RULE techniques) and the importance of partnership of the client and therapist throughout the treatment process.
- Describe specific non-opioid treatment options for various acute and chronic pain conditions
- Identify treatable pain conditions and address them early in order to avoid unnecessary delays in treatment and improve patient outcomes
- Limit use of opioid medication in clinical practice to help prevent long-term complications of opioid addiction, dependence, tolerance, and diversion.
- Help change the public perception/misconception that opioid medications are first-line treatments and/or the only treatments for acute and chronic pain
- Discuss the issues which precipitated the creation of the PMP.
- Identify the primary users of the PMP.
- Summarize the trend of opioid prescription numbers in the state over time.
- Describe the state PMP mandatory use law.
- Comprehend the opioid epidemic
- Apply the Louisiana State Board Opioid Rules to a medical practice
- Discuss the alternatives to long-term opioid use
- Discuss multimodal pain control.
- Discuss clinical orthopedic and related research journal information.
- Define/describe SAMHSA, DATA/X-waiver, and give overview of OUD treatment in this context
- Identify resources for those wishing to obtain the waiver, both for initial certification and ongoing support.
- Review ongoing changes and updates to DATA-waiver requirements.
- Demonstrate use in clinical vignettes to show real-world application of waiver, including cases where it is not required.
- Identify non-opioid drug treatment classes, dosing, side effects, contraindications, drug interactions, and indications for use in adult patients in the ambulatory /outpatient setting
- Choose an appropriate non-opioid drug treatment for common ambulatory/outpatient disease states that require analgesics based on guideline recommendations, patient demographics, contraindications, side effects, dosing, adherence, and costs
- Formulate a treatment plan for monitoring, assessing treatment response, duration of use, follow up, and switching to alternative treatment options
- Apply alternative drug treatment strategies for unique patient populations/clinical scenarios
- Upon completion of this activity the participant will have be able to implement harm reduction strategies in their OUD patients
- Upon completion of this activity the participant will be able to communicate harm reduction and patient safety strategies to both their patients and families
- Reduce stigma when talking to patients concerning treatment of addictive disorders
- To discuss harm reduction when starting MAT and to discuss the concept of “meeting a patient they’re at” while minimizing potential harm